# EDGAR Filing Document

**Accession Number:** 0000835011
**File Stem:** 0000835011-25-000095
**Filing Date:** 2025-10
**Character Count:** 48595
**Document Hash:** 201da18035ff2b93e3b69fe65d89bb2a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000835011-25-000095.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0000835011-25-000095

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251029

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MGP INGREDIENTS INC
- **CENTRAL INDEX KEY:** 0000835011
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-BEER, WINE & DISTILLED ALCOHOLIC BEVERAGES [5180]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 480531200
- **STATE OF INCORPORATION:** KS
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-17196
- **FILM NUMBER:** 251426861

**BUSINESS ADDRESS:**
- **STREET 1:** 1300 MAIN ST
- **CITY:** ATCHISON
- **STATE:** KS
- **ZIP:** 66002
- **BUSINESS PHONE:** 9133671480

**MAIL ADDRESS:**
- **STREET 1:** 1300 MAIN STREET
- **CITY:** ATCHISON
- **STATE:** KS
- **ZIP:** 66002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MIDWEST GRAIN PRODUCTS INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? mgpi-20251029

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D. C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): October 29, 2025

**MGP Ingredients, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Kansas** | **0-17196** | **45-4082531** |
| (State or other jurisdiction <br>of incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**Cray Business Plaza** 

**100 Commercial Street** 

**Box 130** 

**Atchison, Kansas 66002** 

(Address of principal executive offices) (Zip Code)

**(913) 367-1480** 

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, no par value | MGPI | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02. Results of Operations and Financial Condition.** 

On October 29, 2025, MGP Ingredients, Inc. (the "Company") issued a press release relating to financial results for the third quarter 2025, which ended September 30, 2025. A copy of the press release is being furnished as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | <u>[Press release dated October 29, 2025](mgpiq32025ex-991.htm)</u> |
| 104 | The cover page from this Current Report on Form 8-K, formatted in iXBRL (Inline Extensible Business Reporting Language) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MGP INGREDIENTS, INC.

---

| | | |
|:---|:---|:---|
| Date: October 29, 2025 | By: | /s/ Brandon M. Gall |
|  |  | Brandon M. Gall, Chief Financial Officer |

---

## Exhibit 99.1

![picture1.jpg](picture1.jpg)

**MGP INGREDIENTS REPORTS THIRD QUARTER 2025 RESULTS**

*Solid third quarter results; Raises full-year adjusted EBITDA and EPS outlook* 

**ATCHISON, Kan., October 29, 2025** - **MGP Ingredients, Inc. (Nasdaq: MGPI),** a leading provider of branded and distilled spirits and food ingredient solutions, today reported results for the third quarter ended September 30, 2025.

"Our third quarter results demonstrate the resilience of our business and our team's ability to continue to deliver against our key initiatives amid ongoing industry headwinds," said Julie Francis, president and CEO. "Our premium plus brands again delivered solid growth and our brown goods decline came in slightly better than anticipated. In our Ingredient Solutions segment, operational execution was below expectations, and we are taking decisive actions to address those challenges. These efforts, along with the continued focus and commitment of our team, supported solid third quarter results, and we believe they position MGP for sustained long-term value creation."

She added, "Given our year-to-date performance, we are updating our full year adjusted EBITDA and adjusted EPS guidance to a range of $110 million to $115 million and $2.60 to $2.75, respectively, and tightening our full-year sales guidance to a range of $525 million to $535 million."

**2025 third quarter financial highlights compared to 2024 third quarter:**<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated sales decreased 19% to $130.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Consolidated gross profit decreased 25% to $49.4 million. Gross margin decreased by 300 basis points to 37.8%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income decreased 35% to $15.4 million. On an adjusted basis, net income decreased 36% to $18.5 million. Basic earnings per common share ("EPS") decreased to $0.71 per share from $1.07 per share. Adjusted basic EPS decreased 34% to $0.85 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA decreased 29% to $32.3 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Year-to-date operating cash flows increased 26% to $92.5 million compared to the prior-year period as we continue to prioritize strong cash generation by managing our working capital, including barrel inventory put-away.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Year-to-date capital expenditures declined 42% to $25.4 million compared to the year-ago period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net debt leverage ratio stands at approximately 1.8x as of September 30, 2025.

**Consolidated Results**

Third quarter 2025 consolidated sales decreased by 19% compared to the prior-year period primarily due to the expected declines in our brown goods sales. The lower brown goods volume also pressured profitability, leading to a 25% decline in third quarter consolidated gross profit. Operating income decreased to $21.0 million primarily due to lower gross profit. Adjusted operating income decreased to $25.0 million reflecting lower gross profit.

------

Third quarter advertising and promotion expenses decreased 31% to $6.7 million as we continued to realign our spend behind our most attractive growth opportunities. Branded Spirits advertising and promotion spend of $6.3 million was approximately 10% of Branded Spirits segment sales in the third quarter.

**Branded Spirits**

Branded Spirits segment sales decreased 3% to $60.7 million compared to the prior-year quarter. Our premium plus sales increased by 3% delivering another quarter of solid growth, as our targeted focus on our most attractive growth opportunities continues to take hold. Within this portfolio, Penelope Bourbon maintained its strong growth trajectory with another quarter of best-in-class growth among top selling premium plus American whiskey brands. As expected, sales of our mid and value priced portfolios, combined, declined by 7% due to lower volumes of certain cordial and tequila brands. Branded Spirits gross margin increased by 120 basis points to 53.0%, while gross profit moderated slightly to $32.2 million.

**Distilling Solutions**

Distilling Solutions segment sales decreased by 43% to $40.9 million compared to the prior-year quarter, as customer demand for brown goods remained constrained amid elevated industry-wide barrel inventories. Segment profitability also declined, with gross profit down 50% to $14.2 million, or 34.7% of segment sales.

As anticipated, several of our large strategic customers completed their existing contracts and expressed the need to temporarily pause their near-term whiskey purchases as they rebalance their inventories. Our teams remain closely engaged with these customers to align on their future brown goods needs, new product innovation, and opportunities in adjacent categories.

**Ingredient Solutions**

Ingredient Solutions segment sales increased by 9% to $29.3 million compared to the prior-year quarter, primarily driven by higher sales of both specialty and commodity wheat proteins as the conversion of new domestic customers continued during the quarter.

Segment gross profit decreased to $3.0 million, or 10.3% of segment sales, as the benefit of higher sales volumes was offset by higher waste starch disposal costs, elevated costs related to the commercialization of a new large textured protein customer, and operating inefficiencies resulting from the unanticipated outage of a key piece of equipment. We remain focused on improving operational consistency through continued investment in our Atchison facility designed to enhance manufacturing reliability and mitigate disposal costs.

**2025 Financial Outlook** 

MGP provided updated consolidated guidance for fiscal 2025:

---

| | | |
|:---|:---|:---|
| | **Revised** <br>**Fiscal 2025 Guidance** | **Previous** <br>**Fiscal 2025 Guidance** |
| Sales | $525 to $535 million | $520 to $540 million |
| Adjusted EBITDA | $110 to $115 million | $105 to $115 million |
| Adjusted basic EPS | $2.60 to $2.75 | $2.45 to $2.75 |
| Effective tax rate | ~25% | ~25% |
| Basic weighted average shares outstanding | ~ 21.4 million | ~ 21.4 million |
| Capital expenditures | ~ $32.5 million | ~ $32.5 million |

---

------

**Conference Call and Webcast Information**

MGP Ingredients will host a conference call today, October 29, 2025, at 10 a.m. ET to discuss these results and current business trends. Investors can dial 844-308-6398 or 412-717-9605 (international) to listen to the live call. A live webcast will be available at the "News and Events" section of the company's Investor Relations website at ir.mgpingredients.com/news-events. A replay of the conference call will be available on the company's website.

**About MGP Ingredients, Inc.**

MGP Ingredients Inc. (Nasdaq: MGPI) has been formulating excellence since 1941 by bringing product ideas to life across the alcoholic beverage and specialty ingredient industries through three segments: Branded Spirits, Distilling Solutions, and Ingredient Solutions. MGPI is one of the leading spirits distillers with an award-winning portfolio of premium brands including Penelope, Rebel, Remus, and Yellowstone bourbons and El Mayor tequila, under the Luxco umbrella. With distilleries in Indiana and Kentucky; a tequila distillery in Arandas, Mexico; and bottling operations in Missouri, Ohio, and Northern Ireland, the company creates distilled spirits for customers including many world-renowned spirits brands. In addition, the company's high-quality specialty fiber, protein, and starch ingredients provide functional, nutritional, and sensory solutions for a wide range of food products. To learn more visit MGPIngredients.com.

**Cautionary Note Regarding Forward-Looking Statements** 

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements about the ability of MGP Ingredients, Inc. (the "Company" or "MGP") to address operational execution, position the Company for value creation, improve consistency, enhance reliability, and mitigate costs; and the Company's 2025 outlook, including its expectations for sales, adjusted EBITDA, adjusted basic EPS, tax rate, shares outstanding, and capital expenditures. Forward looking statements are usually identified by or are associated with words such as "intend," "plan," "believe," "estimate," "expect," "anticipate," "project," "forecast," "hopeful," "should," "may," "will," "could," "encouraged," "opportunities," "potential," and similar terminology. These forward-looking statements reflect management's current beliefs and estimates of future economic circumstances, industry conditions, Company performance, Company financial results, and Company financial condition and are not guarantees of future performance.

All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. Factors that could cause actual results to differ materially from our expectations include without limitation any effects of changes in consumer preferences and purchases and our ability to anticipate or react to those changes; our ability to compete effectively and any effects of industry dynamics and market conditions; damage to our reputation or that of any of our key customers or their brands; failure to introduce successful new brands and products or have effective marketing or advertising; changes in public opinion about alcohol or our products; our reliance on our distributors to distribute our branded spirits; our reliance on fewer, more profitable customer relationships; interruptions in our operations or a catastrophic event at our facilities; decisions concerning the quantity of maturing stock of our aged distillate; any inability to successfully complete our capital projects or fund capital expenditures or any warehouse expansion issues; our reliance on a limited number of suppliers; work disruptions or stoppages; climate change and measures to address climate change; regulation and taxation and compliance with existing or future laws and regulations; tariffs, trade relations, and trade policies; excise taxes, incentives and customs duties; our ability to protect our intellectual property rights and defend against alleged intellectual property rights infringement claims; failure to secure and maintain listings in control states; labeling or warning requirements or limitations on the availability of our products; product recalls or other product liability claims; anti-corruption laws, trade sanctions, and restrictions; litigation or legal proceedings; limited rights of common stockholders and anti-takeover provisions in our governing documents; the impact of issuing shares of our common stock; higher costs or the unavailability and cost of raw materials, product ingredients, energy resources, or labor; failure of our information technology systems, networks, processes, associated sites, or service providers; acquisitions and potential future acquisitions; interest rate increases; reliance on key personnel; commercial, political, and financial risks; covenants and other provisions in our

------

credit arrangements; pandemics or other health crises; ability to pay any dividends and make any share repurchases; and the effectiveness or execution of our strategic plan. For further information on these risks and uncertainties and other factors that could affect the Company's business, see the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, and September 30, 2025, as well as the Company's other SEC filings. The Company undertakes no obligation to update any forward-looking statements or information in this press release, except as required by law.

**Non-GAAP Financial Measures** 

In addition to reporting financial information in accordance with U.S. GAAP, the Company provides certain non-GAAP financial measures that are not in accordance with, or alternatives for, GAAP. In addition to the comparable GAAP measures, the Company has disclosed adjusted selling, general, and administrative expenses ("SG&A"), adjusted operating income, adjusted income before income taxes, adjusted net income, adjusted MGP earnings, adjusted EBITDA, net debt, net debt leverage ratio, and adjusted basic and diluted EPS, as well as guidance for adjusted EBITDA and adjusted basic EPS. The presentation of these non-GAAP financial measures should be reviewed in conjunction with SG&A, operating income, income before income taxes, net income, net income used in earnings per common share calculation, debt, and basic and diluted EPS computed in accordance with U.S. GAAP and should not be considered a substitute for the GAAP measure. We believe that the non-GAAP measures provide useful information to investors regarding the Company's performance and overall results of operations. In addition, management uses these non-GAAP measures in conjunction with GAAP measures when evaluating the Company's operating results compared to prior periods on a consistent basis, assessing financial trends, and for forecasting purposes. Non-GAAP financial measures may not provide information that is directly comparable to other companies, even if similar terms are used to identify such measures. The attached schedules provide a full reconciliation of historical non-GAAP financial measures to the most directly comparable U.S. GAAP financial measure. Full year 2025 guidance measures of adjusted EBITDA and adjusted basic EPS are provided on a non-GAAP basis without a reconciliation to the most directly comparable GAAP measures because the Company is unable to predict with a reasonable degree of certainty certain items contained in the GAAP measures without unreasonable efforts. Such items include without limitation, acquisition related expenses, restructuring and related expenses, and other items not reflective of the Company's ongoing operations.

**For More Information**

Investors:

Amit Sharma, amit.sharma@mgpingredients.com

Media:

Patrick Barry, 314.540.3865, patrick@byrnepr.net

------

**MGP INGREDIENTS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME** (UNAUDITED)

(Dollars in thousands, except share and per share amounts)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Sales | $**130912** | $161461 | $**398059** | $522829 |
| Cost of sales | **81479** | 95646 | **246909** | 310987 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Gross profit** | **49433** | 65815 | **151150** | 211842 |
| Advertising and promotion expenses | **6691** | 9647 | **21776** | 29995 |
| Selling, general, and administrative expenses | **18926** | 17204 | **63287** | 60942 |
| Impairment of long-lived assets and other | **—** |  | **—** | 137 |
| Change in fair value of contingent consideration | **2800** | 6400 | **25500** | 15900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Operating income** | **21016** | 32564 | **40587** | 104868 |
| Interest expense, net | **(1739)** | (2174) | **(5490)** | (6398) |
| Other income, net | **428** | 1026 | **957** | 1917 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Income before income taxes** | **19705** | 31416 | **36054** | 100387 |
| Income tax expense | **4276** | 7554 | **9255** | 23924 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income** | **15429** | 23862 | **26799** | 76463 |
| Net loss (income) attributable to noncontrolling interest | **(7)** | 43 | **25** | 162 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income attributable to MGP Ingredients, Inc.** | **15422** | 23905 | **26824** | 76625 |
| Income attributable to participating securities | **(190)** | (257) | **(322)** | (828) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net income used in earnings per common share calculation** | $**15232** | $23648 | $**26502** | $75797 |
| **Weighted average common shares** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | **21373300** | 22069885 | **21359051** | 22110315 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | **21373300** | 22069885 | **21359051** | 22110315 |
| **Earnings per common share** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $**0.71** | $1.07 | $**1.24** | $3.43 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $**0.71** | $1.07 | $**1.24** | $3.43 |

---

------

**MGP INGREDIENTS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS** (UNAUDITED)

(Dollars in thousands)

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **ASSETS** | | |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**13447** | $25273 |
| &nbsp;&nbsp;&nbsp;Receivables, net | **106668** | 148488 |
| &nbsp;&nbsp;&nbsp;Inventory | **384523** | 364944 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses | **4130** | 3983 |
| &nbsp;&nbsp;&nbsp;Refundable income taxes | **2006** | 3448 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total current assets** | **510774** | 546136 |
| Property, plant, and equipment | **588443** | 562714 |
| Less accumulated depreciation and amortization | **(261462)** | (246042) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Property, plant, and equipment, net** | **326981** | 316672 |
| Operating lease right-of-use assets, net | **14849** | 15540 |
| Investment in joint venture | **7894** | 7024 |
| Intangible assets, net | **266010** | 268451 |
| Goodwill | **247789** | 247789 |
| Other assets | **2736** | 4173 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $**1377033** | $1405785 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Current maturities of long-term debt | $**6400** | $6400 |
| &nbsp;&nbsp;&nbsp;Accounts payable | **42695** | 66336 |
| &nbsp;&nbsp;&nbsp;Contingent consideration, current | **110800** |  |
| &nbsp;&nbsp;&nbsp;Federal and state excise taxes payable | **2452** | 5358 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other | **21584** | 14356 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total current liabilities** | **183931** | 92450 |
| Long-term debt, less current maturities | **66220** | 121277 |
| Convertible senior notes | **196103** | 195864 |
| Long-term operating lease liabilities | **11483** | 11940 |
| Contingent consideration | **—** | 85300 |
| Other noncurrent liabilities | **2352** | 2981 |
| Deferred income taxes | **63405** | 63430 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | **523494** | 573242 |
| Total equity | **853539** | 832543 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES AND TOTAL EQUITY** | $**1377033** | $1405785 |

---

------

**MGP INGREDIENTS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS** (UNAUDITED)

(Dollars in thousands)

---

| | | |
|:---|:---|:---|
| | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** |
| | **2025** | **2024** |
| Cash Flows from Operating Activities |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $**26799** | $76463 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **17824** | 16298 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **3320** | 2748 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity method investment gain | **(869)** | (1446) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes, including change in valuation allowance | **(25)** | (1084) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **25500** | 15900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | **594** | 429 |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables, net | **41699** | 13979 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory | **(19935)** | (24979) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | **(163)** | (1091) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable (refundable) | **1442** | (2765) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **(8446)** | (10627) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other | **7689** | (9935) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Federal and state excise taxes payable | **(2906)** | 231 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | **(74)** | (609) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by operating activities** | **92449** | 73512 |
| Cash Flows from Investing Activities |  |  |
| &nbsp;&nbsp;&nbsp;Additions to property, plant, and equipment | **(40674)** | (52850) |
| &nbsp;&nbsp;&nbsp;Other, net | **(14)** | (276) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities** | **(40688)** | (53126) |
| Cash Flows from Financing Activities |  |  |
| &nbsp;&nbsp;&nbsp;Payment of dividends and dividend equivalents | **(7739)** | (8013) |
| &nbsp;&nbsp;&nbsp;Repurchase of Common Stock | **(1035)** | (12235) |
| &nbsp;&nbsp;&nbsp;Loan fees paid related to borrowings | **(2712)** |  |
| &nbsp;&nbsp;&nbsp;Proceeds from long-term debt | **28000** | 70000 |
| &nbsp;&nbsp;&nbsp;Principal payments on long-term debt | **(80800)** | (67800) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in financing activities** | **(64286)** | (18048) |
| Effect of exchange rate changes on cash and cash equivalents | **699** | 46 |
| Increase (decrease) in cash and cash equivalents | **(11826)** | 2384 |
| Cash and cash equivalents, beginning of period | **25273** | 18388 |
| Cash and cash equivalents, end of period | $**13447** | $20772 |

---

------

**MGP INGREDIENTS, INC.**

**RECONCILIATION OF SELECTED GAAP MEASURES TO ADJUSTED NON-GAAP MEASURES** (UNAUDITED)

(in thousands, except per share amounts)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter Ended September 30, 2025** | **Quarter Ended September 30, 2025** | **Quarter Ended September 30, 2025** | **Quarter Ended September 30, 2025** | **Quarter Ended September 30, 2025** | **Quarter Ended September 30, 2025** |
| | **SG&A** | **Operating Income** | **Income before Income Taxes** | **Net Income** | **MGP Earnings**<sup>(a)</sup> | **Basic and Diluted EPS** |
| **Reported GAAP Results** | $**18926** | $**21016** | $**19705** | $**15429** | $**15232** | $**0.71** |
| Adjusted to remove: |  |  |  |  |  |  |
| &nbsp;&nbsp;Fair value of contingent consideration<sup>(b)</sup> | **—** | **2800** | **2800** | **2192** | **2169** | **0.10** |
| &nbsp;&nbsp;Executive transition costs <sup>(c)</sup> | **(1143)** | **1143** | **1143** | **895** | **885** | **0.04** |
| **Adjusted Non-GAAP results** | $**17783** | $**24959** | $**23648** | $**18516** | $**18286** | $**0.85** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter Ended September 30, 2024** | **Quarter Ended September 30, 2024** | **Quarter Ended September 30, 2024** | **Quarter Ended September 30, 2024** | **Quarter Ended September 30, 2024** | **Quarter Ended September 30, 2024** |
| | **SG&A** | **Operating Income** | **Income before Income Taxes** | **Net Income** | **MGP Earnings**<sup>(a)</sup> | **Basic and Diluted EPS** |
| **Reported GAAP Results** | $17204 | $32564 | $31416 | $23862 | $23648 | $1.07 |
| Adjusted to remove: |  |  |  |  |  |  |
| &nbsp;&nbsp;Fair value of contingent consideration<sup>(b)</sup> | **—** | 6400 | 6400 | 4864 | 4864 | 0.22 |
| &nbsp;&nbsp;Business acquisition costs <sup>(g)</sup> | (15) | 15 | 15 | 11 | 11 |  |
| &nbsp;&nbsp;Unusual items costs <sup>(h)</sup> | (34) | 34 | 34 | 26 | 26 |  |
| **Adjusted Non-GAAP results** | $17155 | $39013 | $37865 | $28763 | $28549 | $1.29 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year to Date Ended September 30, 2025** | **Year to Date Ended September 30, 2025** | **Year to Date Ended September 30, 2025** | **Year to Date Ended September 30, 2025** | **Year to Date Ended September 30, 2025** | **Year to Date Ended September 30, 2025** |
| | **SG&A** | **Operating Income** | **Income before Income Taxes** | **Net Income** | **MGP Earnings**<sup>(a)</sup> | **Basic and Diluted EPS** |
| **Reported GAAP Results** | $**63287** | $**40587** | $**36054** | $**26799** | $**26502** | $**1.24** |
| Adjusted to remove: |  |  |  |  |  |  |
| &nbsp;&nbsp;Fair value of contingent consideration<sup>(b)</sup> | **—** | **25500** | **25500** | **18947** | **18736** | **0.88** |
| &nbsp;&nbsp;Executive transition costs <sup>(c)</sup> | **(1825)** | **1825** | **1825** | **1356** | **1341** | **0.06** |
| &nbsp;&nbsp;Professional service fees <sup>(d)</sup> | **(382)** | **382** | **382** | **284** | **281** | **0.01** |
| &nbsp;&nbsp;Restructuring and other costs <sup>(e)</sup> | **(613)** | **613** | **613** | **455** | **450** | **0.02** |
| **Adjusted Non-GAAP results** | $**60467** | $**68907** | $**64374** | $**47841** | $**47310** | $**2.21** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year to Date Ended September 30, 2024** | **Year to Date Ended September 30, 2024** | **Year to Date Ended September 30, 2024** | **Year to Date Ended September 30, 2024** | **Year to Date Ended September 30, 2024** | **Year to Date Ended September 30, 2024** |
| | **SG&A** | **Operating Income** | **Income before Income Taxes** | **Net Income** | **MGP Earnings**<sup>(a)</sup> | **Basic and Diluted EPS** |
| **Reported GAAP Results** | $60942 | $104868 | $100387 | $76463 | $75797 | $3.43 |
| Adjusted to remove: |  |  |  |  |  |  |
| &nbsp;&nbsp;Impairment of long-lived assets and other <sup>(f)</sup> |  | 137 | 137 | 104 | 104 |  |
| &nbsp;&nbsp;Fair value of contingent consideration<sup>(b)</sup> |  | 15900 | 15900 | 12116 | 12116 | 0.55 |
| &nbsp;&nbsp;Business acquisition costs <sup>(g)</sup> | (101) | 101 | 101 | 77 | 77 |  |
| &nbsp;&nbsp;Executive transition costs <sup>(c)</sup> | (1218) | 1218 | 1218 | 928 | 928 | 0.04 |
| &nbsp;&nbsp;Unusual items costs <sup>(h)</sup> | (1673) | 1673 | 1673 | 1275 | 1275 | 0.06 |
| **Adjusted Non-GAAP results** | $57950 | $123897 | $119416 | $90963 | $90297 | $4.08 |

---

------

**MGP INGREDIENTS, INC.**

**DESCRIPTION OF NON-GAAP ITEMS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)MGP Earnings is defined as "Net income used in Earnings Per Common Share calculation," which accounts for the impacts of the net loss attributable to noncontrolling interest and income attributable to participating securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Fair value of contingent consideration relates to the quarterly adjustment of the contingent consideration liability related to the acquisition of Penelope Bourbon LLC. It is included in the Condensed Consolidated Statement of Income as a component of operating income and relates to the Branded Spirits segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The executive transition costs are included in the Condensed Consolidated Statement of Income within the selling, general, and administrative line item. The adjustment includes costs related to the transition of certain executive and board of director positions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The professional services fees are included in the Condensed Consolidated Statement of Income within the selling, general, and administrative line item. The adjustment includes costs related to professional services in conjunction with the goodwill impairment valuation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)The restructuring and other costs are included in the Condensed Consolidated Statement of Income within the selling, general, and administrative line item. The adjustment includes special one-time severance costs related to the reduction in force that occurred during the period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)The impairment of long-lived assets and other relates to impairments of assets as well as miscellaneous expenses in connection with the closure of the Atchison distillery. Impairment of long-lived assets and other are included in the Condensed Consolidated Statement of Income as a component of operating income and relates to the Distilling Solutions segment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)Business acquisition costs are included in the Condensed Consolidated Statement of Income within the selling, general, and administrative line item and include transaction and integration costs associated with the acquisition of Penelope Bourbon LLC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)The unusual items costs are included in the Condensed Consolidated of Income within the selling, general, and administrative line item. The adjustment includes professional and legal costs associated with special projects.

------

**MGP INGREDIENTS, INC.**

**RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA** (UNAUDITED)

(in thousands)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Net Income** | $**15429** | $23862 | $**26799** | $76463 |
| &nbsp;&nbsp;&nbsp;Interest expense | **1739** | 2174 | **5490** | 6398 |
| &nbsp;&nbsp;&nbsp;Income tax expense | **4276** | 7554 | **9255** | 23924 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | **6186** | 5680 | **17824** | 16298 |
| &nbsp;&nbsp;Share based compensation <sup>(a)</sup> | **1057** | 767 | **3087** | 2748 |
| &nbsp;&nbsp;&nbsp;Equity method investment gain | **(375)** | (832) | **(869)** | (1446) |
| &nbsp;&nbsp;&nbsp;Fair value of contingent consideration | **2800** | 6400 | **25500** | 15900 |
| &nbsp;&nbsp;&nbsp;Executive transition costs | **1143** |  | **1825** | 1218 |
| &nbsp;&nbsp;&nbsp;Professional service fees | **—** | **—** | **382** |  |
| &nbsp;&nbsp;&nbsp;Restructuring and other costs | **—** |  | **613** |  |
| &nbsp;&nbsp;&nbsp;Impairment of long-lived assets and other | **—** |  | **—** | 137 |
| &nbsp;&nbsp;&nbsp;Business acquisition costs | **—** | 15 | **—** | 101 |
| &nbsp;&nbsp;&nbsp;Unusual items costs | **—** | 34 | **—** | 1673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted EBITDA** | $**32255** | $45654 | $**89906** | $143414 |

---

(a) This amount excludes share based compensation related to executive transition costs.

The non-GAAP adjusted EBITDA measure is defined as earnings before interest expense, income tax expense, depreciation and amortization, share based compensation, equity method investment gain, fair value of contingent consideration, executive transition costs, professional service fees, restructuring and other costs, impairment of long-lived assets and other, business acquisition costs, and unusual items costs.

See "Reconciliation of selected GAAP measure to adjusted non-GAAP measures" and "Description of Non-GAAP items" for further details on selected non-GAAP items.

------

**MGP INGREDIENTS, INC.**

**NET DEBT LEVERAGE RATIO** (UNAUDITED)

(in thousands)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter Ended <br>December 31, <br>2024** | **Quarter Ended <br>March 31, <br>2024** | **Quarter Ended <br>June 30, <br>2025** | **Quarter Ended <br>September 30, <br>2025** | **TTM**<sup>(a)</sup><br>**September 30, 2025** |
| Net income (loss) | $(41998) | $(3057) | $14427 | $15429 | $**(15199)** |
| &nbsp;&nbsp;&nbsp;Interest expense | 2041 | 1854 | 1897 | 1739 | **7531** |
| &nbsp;&nbsp;&nbsp;Income tax expense | 10053 | 671 | 4308 | 4276 | **19308** |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 5691 | 5808 | 5830 | 6186 | **23515** |
| &nbsp;&nbsp;&nbsp;Share based compensation | 440 | 742 | 1288 | 1057 | **3527** |
| &nbsp;&nbsp;&nbsp;Equity method investment gain | (381) | (257) | (237) | (375) | **(1250)** |
| &nbsp;&nbsp;&nbsp;Fair value of contingent consideration | 200 | 14700 | 8000 | 2800 | **25700** |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | 73755 |  |  |  | **73755** |
| &nbsp;&nbsp;&nbsp;Professional service fees |  | 382 |  |  | **382** |
| &nbsp;&nbsp;&nbsp;Business acquisition costs | 15 |  |  |  | **15** |
| &nbsp;&nbsp;&nbsp;Executive transition costs | 2857 | 306 | 376 | 1143 | **4682** |
| &nbsp;&nbsp;&nbsp;Restructuring and other costs |  | 613 |  |  | **613** |
| &nbsp;&nbsp;&nbsp;Unusual items costs | 408 |  |  |  | **408** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted EBITDA** | $53081 | $21762 | $35889 | $32255 | $**142987** |
| Total debt |  |  |  |  | $**268723** |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents |  |  |  |  | **13447** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net debt** |  |  |  |  | $**255276** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net debt leverage ratio**<sup>(b)</sup> |  |  |  |  | **1.8** |

---

(a) TTM is defined as trailing twelve months.

(b) Net debt leverage ratio is defined as net debt divided by adjusted EBITDA.

See "Reconciliation of selected GAAP measure to adjusted non-GAAP measures" and "Description of Non-GAAP items" for further details on selected non-GAAP items.

------

**MGP INGREDIENTS, INC.**

**OPERATING SEGMENT RESULTS** (UNAUDITED)

(Dollars in thousands)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BRANDED SPIRITS** | **BRANDED SPIRITS** | **BRANDED SPIRITS** | **BRANDED SPIRITS** | |
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Quarter versus Quarter Change Increase/(Decrease)** | **Quarter versus Quarter Change Increase/(Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Premium plus | $**32119** | $31086 | $1033 | 3% |  |
| Mid | **14835** | 14788 | 47 |  |  |
| Value | **8170** | 10034 | (1864) | (19) |  |
| Other | **5624** | 6716 | (1092) | (16) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Branded Spirits Sales** | $**60748** | $62624 | $(1876) | (3)% |  |
| **Gross profit** | $**32220** | $32446 | $(226) | (1)% |  |
| **Gross margin %** | **53.0%** | 51.8% |  | 1.2 | pp<sup>(a)</sup> |
| Operating income | $**14751** | $7391 | $7360 | 100% |  |
| Depreciation and amortization | $**2157** | $2192 | $(35) | (2)% |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **DISTILLING SOLUTIONS** | **DISTILLING SOLUTIONS** | **DISTILLING SOLUTIONS** | **DISTILLING SOLUTIONS** | |
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Quarter versus Quarter Change Increase/(Decrease)** | **Quarter versus Quarter Change Increase/(Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Brown goods | $**28512** | $57110 | $(28598) | (50)% |  |
| Warehouse services | **8052** | 8264 | (212) | (3) |  |
| White goods and other co-products | **4317** | 6545 | (2228) | (34) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Distilling Solutions Sales** | $**40881** | $71919 | $(31038) | (43)% |  |
| **Gross profit** | $**14200** | $28644 | $(14444) | (50)% |  |
| **Gross margin %** | **34.7%** | 39.8% |  | (5.1) | pp<sup>(a)</sup> |
| Operating income | $**13304** | $27631 | $(14327) | (52)% |  |
| Depreciation and amortization | $**2041** | $1975 | $66 | 3% |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | |
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Quarter versus Quarter Change Increase / (Decrease)** | **Quarter versus Quarter Change Increase / (Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Specialty wheat starches | $**16965** | $16172 | $793 | 5% |  |
| Specialty wheat proteins | **8905** | 7752 | 1153 | 15 |  |
| Commodity wheat starches | **2317** | 2611 | (294) | (11) |  |
| Commodity wheat proteins | **993** | 383 | 610 | 159 |  |
| Biofuel and other | **103** |  | 103 | n/a |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Ingredient Solutions** | $**29283** | $**26918** | $2365 | 9% |  |
| **Gross profit** | $**3013** | $4725 | $(1712) | (36)% |  |
| **Gross margin %** | **10.3%** | 17.6% |  | (7.3) | pp<sup>(a)</sup> |
| Operating income | $**1809** | $3277 | $(1468) | (45)% |  |
| Depreciation and amortization | $**1635** | $1178 | $457 | 39% |  |

---

<sup>(a)</sup> Percentage points ("pp").

------

**MGP INGREDIENTS, INC.**

**OPERATING SEGMENT RESULTS** (UNAUDITED)

(Dollars in thousands)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **BRANDED SPIRITS SALES** | **BRANDED SPIRITS SALES** | **BRANDED SPIRITS SALES** | **BRANDED SPIRITS SALES** | |
| | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Premium plus | $**85536** | $82699 | $2837 | 3% |  |
| Mid | **43355** | 46610 | (3255) | (7) |  |
| Value | **24447** | 31698 | (7251) | (23) |  |
| Other | **16157** | 15804 | 353 | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Branded Spirits** | $**169495** | $176811 | $(7316) | (4)% |  |
| **Gross profit** | $**86402** | $88611 | $(2209) | (2)% |  |
| **Gross margin %** | **51.0%** | 50.1% |  | 0.9 | pp<sup>(a)</sup> |
| Operating income | $**14342** | $15534 | $(1192) | (8)% |  |
| Depreciation and amortization | $**6442** | $5867 | $575 | 10% |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **DISTILLING SOLUTIONS SALES** | **DISTILLING SOLUTIONS SALES** | **DISTILLING SOLUTIONS SALES** | **DISTILLING SOLUTIONS SALES** | |
| | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Brown goods | $**97225** | $198884 | $(101659) | (51)% |  |
| Warehouse services | **24130** | 24612 | (482) | (2) |  |
| White goods and other co-products | **16469** | 26663 | (10194) | (38) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Distilling Solutions** | $**137824** | $250159 | $(112335) | (45)% |  |
| **Gross profit** | $**51692** | $105200 | $(53508) | (51)% |  |
| **Gross margin %** | **37.5%** | 42.1% |  | (4.6) | pp<sup>(a)</sup> |
| Operating income | $**48927** | $102228 | $(53301) | (52)% |  |
| Depreciation and amortization | $**6121** | $5900 | $221 | 4% |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | **INGREDIENT SOLUTIONS SALES** | |
| | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | **Year to Date versus Year to Date Sales Change Increase/(Decrease)** | |
| | **2025** | **2024** | **$ Change** | **% Change** | |
| Specialty wheat starches | $**51292** | $57646 | $(6354) | (11)% |  |
| Specialty wheat proteins | **28865** | 28947 | (82) |  |  |
| Commodity wheat starches | **8097** | 8846 | (749) | (8) |  |
| Commodity wheat proteins | **2383** | 420 | 1963 | 467 |  |
| Biofuel and other | **103** |  | 103 | n/a |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Ingredient Solutions** | $**90740** | $95859 | $(5119) | (5)% |  |
| **Gross profit** | $**13056** | $18031 | $(4975) | (28)% |  |
| **Gross margin %** | **14.4%** | 18.8% |  | (4.4) | pp<sup>(a)</sup> |
| Operating income | $**9107** | $13781 | $(4674) | (34)% |  |
| Depreciation and amortization | $**4213** | $3517 | $696 | 20% |  |

---

<sup>(a)</sup> Percentage points ("pp").

------

**MGP INGREDIENTS, INC.**

**DILUTIVE SHARES OUTSTANDING CALCULATION** (UNAUDITED)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter Ended September 30,** | **Quarter Ended September 30,** | **Year to Date Ended September 30,** | **Year to Date Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Principal amount of the bonds | $**201250000** | $201250000 | $**201250000** | $201250000 |
| Par value | $**1000** | $1000 | $**1000** | $1000 |
| Number of bonds outstanding (a) | **201250** | 201250 | **201250** | 201250 |
| Initial conversion rate | **10.3911** | 10.3911 | **10.3911** | 10.3911 |
| Conversion price | $**96.23620** | $96.23620 | $**96.23620** | $96.23620 |
| Average share price (b) | $**28.99063** | $82.66859 | $**30.67755** | $82.41075 |
| Impact of conversion (c) | $**—** | $— | $**—** | $— |
| Cash paid for principal | **(201250000)** | (201250000) | **(201250000)** | (201250000) |
| **Conversion premium** | $— | $— | $**—** | $— |
| Average share price | $**28.99063** | $82.66859 | $**30.67755** | $82.41075 |
| **Conversion premium in shares (d) (e)** | **—** |  | **—** |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Number of bonds outstanding is calculated by taking the principal amount of the bonds divided by the par value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Average share price is calculated by taking the average of the daily closing share price for the period. If the average share price is less than the conversion price of $96.23620 per share, the impact to EPS is anti-dilutive and therefore the shares were excluded from the diluted EPS calculation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Impact of conversion is calculated by taking the number of bonds outstanding multiplied by the initial conversion rate multiplied by the average share price. If the average share price is less than the conversion price then the impact of conversion is zero.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The impacts of the Convertible Senior Notes are included in the diluted weighted average common shares outstanding if the impact is dilutive. The Convertible Senior Notes would only have a dilutive impact if the average market price per share during the quarter exceed the conversion price of $96.23620 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)Conversion premium in shares is calculated by taking the conversion premium divided by the average share price. If the average share price is less than the conversion price, then the conversion premium in shares is zero.

<br>